Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Pharmaceuticals in tap water: human health risk assessment and proposed monitoring framework in China.

Leung HW, Jin L, Wei S, Tsui MM, Zhou B, Jiao L, Cheung PC, Chun YK, Murphy MB, Lam PK.

Environ Health Perspect. 2013 Jul;121(7):839-46. doi: 10.1289/ehp.1206244. Epub 2013 May 10.

2.

Determination of selected pharmaceuticals in tap water and drinking water treatment plant by high-performance liquid chromatography-triple quadrupole mass spectrometer in Beijing, China.

Cai MQ, Wang R, Feng L, Zhang LQ.

Environ Sci Pollut Res Int. 2015 Feb;22(3):1854-67. doi: 10.1007/s11356-014-3473-8. Epub 2014 Sep 9.

PMID:
25196960
3.

Occurrence and human health risk of wastewater-derived pharmaceuticals in a drinking water source for Shanghai, East China.

Wen ZH, Chen L, Meng XZ, Duan YP, Zhang ZS, Zeng EY.

Sci Total Environ. 2014 Aug 15;490:987-93. doi: 10.1016/j.scitotenv.2014.05.087. Epub 2014 Jun 7.

PMID:
24914528
4.

Pharmaceuticals and personal care products in the aquatic environment in China: a review.

Bu Q, Wang B, Huang J, Deng S, Yu G.

J Hazard Mater. 2013 Nov 15;262:189-211. doi: 10.1016/j.jhazmat.2013.08.040. Epub 2013 Aug 28. Review.

PMID:
24036145
5.

Occurrences of pharmaceuticals in drinking water sources of major river watersheds, China.

Sun J, Luo Q, Wang D, Wang Z.

Ecotoxicol Environ Saf. 2015 Jul;117:132-40. doi: 10.1016/j.ecoenv.2015.03.032. Epub 2015 Apr 5.

PMID:
25847753
6.

Occurrence of pharmaceuticals in a water supply system and related human health risk assessment.

de Jesus Gaffney V, Almeida CM, Rodrigues A, Ferreira E, Benoliel MJ, Cardoso VV.

Water Res. 2015 Apr 1;72:199-208. doi: 10.1016/j.watres.2014.10.027. Epub 2014 Oct 20.

PMID:
25453834
7.

Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment.

Kosma CI, Lambropoulou DA, Albanis TA.

Sci Total Environ. 2014 Jan 1;466-467:421-38. doi: 10.1016/j.scitotenv.2013.07.044. Epub 2013 Aug 7.

PMID:
23933429
8.

Human health risk assessment of the mixture of pharmaceuticals in Dutch drinking water and its sources based on frequent monitoring data.

Houtman CJ, Kroesbergen J, Lekkerkerker-Teunissen K, van der Hoek JP.

Sci Total Environ. 2014 Oct 15;496:54-62. doi: 10.1016/j.scitotenv.2014.07.022. Epub 2014 Jul 22.

PMID:
25058934
9.

Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health.

Simazaki D, Kubota R, Suzuki T, Akiba M, Nishimura T, Kunikane S.

Water Res. 2015 Jun 1;76:187-200. doi: 10.1016/j.watres.2015.02.059. Epub 2015 Mar 12.

PMID:
25835589
10.

Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea.

Choi K, Kim Y, Park J, Park CK, Kim M, Kim HS, Kim P.

Sci Total Environ. 2008 Nov 1;405(1-3):120-8. doi: 10.1016/j.scitotenv.2008.06.038. Epub 2008 Aug 6.

PMID:
18684486
11.

Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water.

de Jongh CM, Kooij PJ, de Voogt P, ter Laak TL.

Sci Total Environ. 2012 Jun 15;427-428:70-7. doi: 10.1016/j.scitotenv.2012.04.010. Epub 2012 May 1.

PMID:
22551934
12.

Occurrence of pharmaceuticals and personal care products and associated environmental risks in the central and lower Yangtze river, China.

Wu C, Huang X, Witter JD, Spongberg AL, Wang K, Wang D, Liu J.

Ecotoxicol Environ Saf. 2014 Aug;106:19-26. doi: 10.1016/j.ecoenv.2014.04.029. Epub 2014 May 14.

PMID:
24836873
13.

Assessing the effects of tertiary treated wastewater reuse on the presence emerging contaminants in a Mediterranean river (Llobregat, NE Spain).

López-Serna R, Postigo C, Blanco J, Pérez S, Ginebreda A, de Alda ML, Petrović M, Munné A, Barceló D.

Environ Sci Pollut Res Int. 2012 May;19(4):1000-12. doi: 10.1007/s11356-011-0596-z. Epub 2012 Apr 29.

PMID:
22544553
14.

Environmental exposure of pharmaceuticals and musk fragrances in the Somes River before and after upgrading the municipal wastewater treatment plant Cluj-Napoca, Romania.

Moldovan Z, Chira R, Alder AC.

Environ Sci Pollut Res Int. 2009 Aug;16 Suppl 1:S46-54. doi: 10.1007/s11356-008-0047-7. Epub 2008 Oct 30.

PMID:
18972147
15.

Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China.

Zhao JL, Ying GG, Liu YS, Chen F, Yang JF, Wang L, Yang XB, Stauber JL, Warne MS.

Environ Toxicol Chem. 2010 Jun;29(6):1377-84. doi: 10.1002/etc.161.

PMID:
20821582
16.

Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.

Liebig M, Moltmann JF, Knacker T.

Environ Sci Pollut Res Int. 2006 Mar;13(2):110-9.

PMID:
16612900
17.

Risk assessment on the presence of pharmaceuticals in sediments, soils and waters of the Pego-Oliva Marshlands (Valencia, eastern Spain).

Vazquez-Roig P, Andreu V, Blasco C, Picó Y.

Sci Total Environ. 2012 Dec 1;440:24-32. doi: 10.1016/j.scitotenv.2012.08.036. Epub 2012 Sep 27.

PMID:
23021792
18.

Drugs of abuse, cytostatic drugs and iodinated contrast media in tap water from the Madrid region (central Spain):A case study to analyse their occurrence and human health risk characterization.

Mendoza A, Zonja B, Mastroianni N, Negreira N, López de Alda M, Pérez S, Barceló D, Gil A, Valcárcel Y.

Environ Int. 2016 Jan;86:107-18. doi: 10.1016/j.envint.2015.11.001. Epub 2015 Nov 10.

PMID:
26571428
19.

Occurrence and risk assessment of pharmaceuticals and personal care products and endocrine disrupting chemicals in reclaimed water and receiving groundwater in China.

Li Z, Xiang X, Li M, Ma Y, Wang J, Liu X.

Ecotoxicol Environ Saf. 2015 Sep;119:74-80. doi: 10.1016/j.ecoenv.2015.04.031. Epub 2015 May 14.

PMID:
25982733
20.

Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.

Ritter L, Solomon K, Sibley P, Hall K, Keen P, Mattu G, Linton B.

J Toxicol Environ Health A. 2002 Jan 11;65(1):1-142. Review.

PMID:
11809004

Supplemental Content

Support Center